Journal of Clinical Medicine,
Год журнала:
2020,
Номер
9(1), С. 272 - 272
Опубликована: Янв. 19, 2020
Chronic
kidney
disease
has
become
a
major
medical
issue
in
recent
years
due
to
its
high
prevalence
worldwide,
association
with
premature
mortality,
and
social
economic
implications.
A
number
of
patients
gradually
progress
end-stage
renal
(ESRD),
requiring
then
dialysis
transplantation.
Currently,
approximately
40%
diabetes
develop
disease,
making
it
the
most
prevalent
cause
ESRD.
Thus,
more
effective
therapies
for
diabetic
nephropathy
are
needed.
In
preclinical
studies
diabetes,
anti-inflammatory
therapeutic
strategies
have
been
used
protect
kidneys.
Recent
evidence
supports
that
immune
cells
play
an
active
role
pathogenesis
nephropathy.
Th17
their
effector
cytokine
IL-17A
recently
emerged
as
promising
targets
several
clinical
conditions,
including
diseases.
Here,
we
review
current
knowledge
regarding
involvement
Th17/IL-17A
genesis
injury,
well
rationale
behind
targeting
additional
therapy
Circulation Research,
Год журнала:
2022,
Номер
131(1), С. 77 - 90
Опубликована: Май 10, 2022
miRNA
therapeutics
have
gained
attention
during
the
past
decade.
These
oligonucleotide
treatments
can
modulate
expression
of
miRNAs
in
vivo
and
could
be
used
to
correct
imbalance
gene
found
human
diseases
such
as
obesity,
metabolic
syndrome,
atherosclerosis.
The
efficacy
current
anti-miRNA
technologies
hindered
by
physiological
cellular
barriers
delivery
into
targeted
cells
nature
that
allows
one
target
an
entire
pathway
may
lead
deleterious
off-target
effects.
For
these
reasons,
novel
systems
inhibit
specific
tissues
will
important
for
developing
effective
therapeutic
strategies
numerous
including
Idiopathic
pulmonary
fibrosis
(IPF)
is
a
progressive
and
ultimately
fatal
disease.
Recent
findings
have
shown
marked
metabolic
reprogramming
associated
with
changes
in
mitochondrial
homeostasis
autophagy
during
fibrosis.
The
microRNA-33
(miR-33)
family
of
microRNAs
(miRNAs)
encoded
within
the
introns
sterol
regulatory
element
binding
protein
(SREBP)
genes
are
master
regulators
fatty
acid
(FA)
metabolism.
miR-33
controls
macrophage
immunometabolic
response
enhances
biogenesis,
FA
oxidation,
cholesterol
efflux.
Here,
we
show
that
levels
increased
bronchoalveolar
lavage
(BAL)
cells
isolated
from
patients
IPF
compared
healthy
controls.
We
demonstrate
specific
genetic
ablation
macrophages
protects
against
bleomycin-induced
absence
improves
increases
while
decreasing
inflammatory
after
bleomycin
injury.
Notably,
pharmacological
inhibition
via
administration
anti-miR-33
peptide
nucleic
acids
(PNA-33)
attenuates
different
vivo
ex
mice
human
models
These
studies
elucidate
major
role
regulation
uncover
potentially
novel
therapeutic
approach
to
treat
this
Nature Communications,
Год журнала:
2024,
Номер
15(1)
Опубликована: Март 8, 2024
Abstract
AgRP
neurons
drive
hunger,
and
excessive
nutrient
intake
is
the
primary
driver
of
obesity
associated
metabolic
disorders.
While
many
factors
impacting
central
regulation
feeding
behavior
have
been
established,
role
microRNAs
in
this
process
poorly
understood.
Utilizing
unique
mouse
models,
we
demonstrate
that
miR-33
plays
a
critical
neurons,
loss
leads
to
increased
feeding,
obesity,
dysfunction
mice.
These
effects
include
multiple
target
genes
involved
mitochondrial
biogenesis
fatty
acid
metabolism.
Our
findings
elucidate
key
regulatory
pathway
regulated
by
non-coding
RNA
impacts
hunger
controlling
bioenergetic
processes
with
activation
providing
alternative
therapeutic
approaches
modulate
diseases.
RNA
therapeutics
have
emerged
as
next-generation
therapy
for
the
treatment
of
many
diseases.
Unlike
small
molecules,
targeted
drugs
are
not
limited
by
availability
binding
pockets
on
protein,
but
rather
utilize
Watson-Crick
(WC)
base-pairing
rules
to
recognize
target
and
modulate
gene
expression.
Antisense
oligonucleotides
(ASOs)
present
a
powerful
therapeutic
approach
treat
disorders
triggered
genetic
alterations.
ASOs
cognate
site
alter
Nine
single-stranded
been
approved
clinical
use
several
candidates
in
late-stage
trials
both
rare
common
Several
chemical
modifications,
including
phosphorothioates,
locked
nucleic
acid,
phosphorodiamidate,
morpholino,
peptide
acids
(PNAs),
investigated
efficient
targeting.
PNAs
synthetic
DNA
mimics
where
deoxyribose
phosphate
backbone
is
replaced
N-(2-aminoethyl)-glycine
units.
The
neutral
pseudopeptide
contributes
enhanced
affinity
high
biological
stability.
hybridize
with
complementary
act
steric
hindrance--based
mechanism.
In
last
three
decades,
various
PNA
designs,
delivery
strategies
explored
demonstrate
their
potential
an
effective
safe
RNA-targeting
platform.
This
review
covers
advances
PNA-mediated
targeting
coding
noncoding
RNAs
myriad
applications.
Redox Biology,
Год журнала:
2023,
Номер
68, С. 102957 - 102957
Опубликована: Ноя. 3, 2023
Progressive
respiratory
failure
is
the
primary
cause
of
death
in
coronavirus
disease
2019
(COVID-19)
pandemic.
It
final
outcome
acute
distress
syndrome
(ARDS),
characterized
by
an
initial
exacerbated
inflammatory
response,
metabolic
derangement
and
ultimate
tissue
scarring.
A
positive
balance
cellular
energy
may
result
crucial
for
recovery
clinical
COVID-19.
Hence,
we
asked
if
two
key
pathways
involved
generation,
AMP-activated
protein
kinase
(AMPK)/acetyl-CoA
carboxylase
(ACC)
signaling
fatty
acid
oxidation
(FAO)
could
be
beneficial.
We
tested
drugs
metformin
(AMPK
activator)
baicalin
(CPT1A
different
experimental
models
mimicking
COVID-19
associated
inflammation
lung
kidney.
also
studied
cohorts
patients
that
had
been
previously
treated
with
metformin.
These
ameliorated
damage
ARDS
animal
model,
while
activation
AMPK/ACC
increased
mitochondrial
function
decreased
TGF-β-induced
fibrosis,
apoptosis
markers
epithelial
cells.
Similar
results
were
observed
indole
derivatives,
IND6
IND8
AMPK
activating
capacity.
Consistently,
a
reduced
time
hospitalization
need
intensive
care
was
exposed
to
Baicalin
mitigated
pro-inflammatory
bone
marrow-derived
macrophages
(BMDMs)
kidney
fibrosis
injury,
another
target
In
human
cells,
both
improved
prevented
renal
cell
dedifferentiation.
Our
support
favoring
production
through
enhanced
FAO
prove
useful
prevention
COVID-19-induced
damage.
FEBS Open Bio,
Год журнала:
2023,
Номер
13(7), С. 1154 - 1163
Опубликована: Фев. 1, 2023
Fibrosis
driven
by
excessive
accumulation
of
extracellular
matrix
(ECM)
is
the
hallmark
chronic
kidney
disease
(CKD).
Myofibroblasts,
which
are
cells
responsible
for
ECM
production,
activated
cross
talk
with
injured
proximal
tubule
and
immune
cells.
Emerging
evidence
suggests
that
alterations
in
metabolism
not
only
a
feature
but
also
play
an
influential
role
pathogenesis
renal
fibrosis.
The
application
omics
technologies
to
cell-tracing
animal
models
follow-up
functional
data
suggest
cell-type-specific
metabolic
shifts
have
particular
roles
fibrogenic
response.
In
this
review,
we
cover
main
reprogramming
outcomes
fibrosis
provide
future
perspective
on
field
fibrometabolism.
DNA and Cell Biology,
Год журнала:
2025,
Номер
unknown
Опубликована: Март 21, 2025
The
occurrence
of
diabetic
kidney
disease
(DKD),
a
critical
microvascular
issue
in
diabetes,
is
progressively
on
the
rise.
In
recent
years,
long
noncoding
RNAs
(lncRNAs)
have
garnered
considerable
attention
as
novel
and
layer
biological
regulation.
Our
knowledge
regarding
roles
underlying
mechanisms
lncRNAs
various
diseases,
including
DKD,
continues
to
evolve.
Similarly,
microRNAs
(miRNAs),
which
are
small
RNAs,
been
recognized
crucial
contributors
cellular
processes
pathogenesis.
Emerging
studies
highlighted
complex
interactions
between
miRNAs,
particularly
context
underscoring
their
importance
human
diseases.
Renal
intrinsic
cell
damage
an
important
cause
inducing
DKD.
Persistent
high
glucose
stimulation
leads
remodeling
renal
cells
cascade
pathological
changes.
This
article
aims
review
literature
lncRNAs-mediated
regulation
miRNAs
affecting
DKD
propose
molecular-level
therapeutic
strategies
for
Through
in-depth
investigation
this
dynamic
molecular
interaction,
we
can
gain
profound
understanding
potential
nephropathy,
potentially
identifying
new
targets
intervention
paving
way
personalized
effective
treatments.
Frontiers in Bioengineering and Biotechnology,
Год журнала:
2020,
Номер
8
Опубликована: Апрель 28, 2020
The
advantages
of
targeted
therapy
have
motivated
many
efforts
to
find
distinguishing
features
between
the
molecular
cell
surface
landscapes
diseased
and
normal
cells.
Typically,
been
proteins,
lipids
or
carbohydrates,
but
other
approaches
are
emerging.
In
this
discussion,
we
examine
use
acidity
as
a
feature
that
can
be
exploited
by
using
pH-sensitive
peptide
folding
target
agents
surfaces
cytoplasms.